Literature DB >> 16699309

Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.

Robert F Bradley1, John H Stewart, Gregory B Russell, Edward A Levine, Kim R Geisinger.   

Abstract

Pseudomyxoma peritonei is a clinical term for gelatinous ascites, usually secondary to an appendiceal tumor. The pathologic classification of pseudomyxoma peritonei and its associated appendiceal tumors has been plagued with controversy and confusing terminology. In an effort to clarify this, we reviewed the pathology of 101 patients, all treated at our institution from 1993 to 2005, with pseudomyxoma peritonei of appendiceal origin. All patients were uniformly treated with our standardized protocol. This is the largest pathologic series solely devoted to appendiceal neoplasia with gelatinous ascites. The cases were assigned, according to previously published criteria, to the categories of disseminated peritoneal adenomucinosis (DPAM), peritoneal mucinous carcinomatosis (PMCA), or PMCA with intermediate (well differentiated) features (PMCA-I), with the exception that any case with a signet-ring cell component was considered as PMCA and not PMCA-I. By histologic category, 58 patients had DPAM, 23 were PMCA, and 20 were PMCA-I.One-year, 3-year, and 5-year survival outcomes were not significantly different between DPAM and PMCA-I. DPAM and PMCA-I also exhibited a roughly equal incidence of parenchymal (beyond the serosa) organ invasion. Survival outcomes were significantly worse for PMCA, compared with PMCA-I and DPAM. After reviewing our data and the literature, mucinous carcinoma peritonei-low grade was applied to the low-grade histology of pseudomyxoma peritonei, including those cases referred to by some as DPAM in the same category as PMCA-I. Cases that are moderately differentiated to poorly differentiated are classified as mucinous carcinoma peritonei-high grade.

Entities:  

Mesh:

Year:  2006        PMID: 16699309     DOI: 10.1097/01.pas.0000202039.74837.7d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  87 in total

1.  Pseudomyxoma peritonei.

Authors:  Katharine E Bevan; Faheez Mohamed; Brendan J Moran
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

2.  Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.

Authors:  Haroon Asif Choudry; Arun Mavanur; Mark E O'Malley; Herbert J Zeh; Z Sheng Guo; David L Bartlett
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

3.  Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms.

Authors:  Frances Austin; Arun Mavanur; Magesh Sathaiah; Jennifer Steel; Diana Lenzner; Lekshmi Ramalingam; Matthew Holtzman; Steven Ahrendt; James Pingpank; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

4.  Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix.

Authors:  Edward A Levine; Konstantinos I Votanopoulos; Shadi A Qasem; John Philip; Kathleen A Cummins; Jeff W Chou; Jimmy Ruiz; Ralph D'Agostino; Perry Shen; Lance D Miller
Journal:  J Am Coll Surg       Date:  2015-12-21       Impact factor: 6.113

5.  High-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.

Authors:  Swaroop R Bommareddi; Vlad V Simianu; Lisa V Mann; Gary N Mann
Journal:  J Surg Oncol       Date:  2015-08-14       Impact factor: 3.454

6.  Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Philipp Horvath; Can Yurttas; Philipp Birk; Florian Struller; Alfred Königsrainer
Journal:  Langenbecks Arch Surg       Date:  2018-12-01       Impact factor: 3.445

7.  The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre.

Authors:  Lawson Ung; Terence C Chua; David L Morris
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-21       Impact factor: 4.553

8.  Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin.

Authors:  S Joseph Sirintrapun; Aaron U Blackham; Greg Russell; Konstantinos Votanopoulos; John H Stewart; Perry Shen; Edward A Levine; Kim R Geisinger; Simon Bergman
Journal:  Hum Pathol       Date:  2014-04-04       Impact factor: 3.466

9.  Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  Alvaro Arjona-Sanchez; Francisco Cristobal Muñoz-Casares; Angela Casado-Adam; Juan Manuel Sánchez-Hidalgo; Maria Dolores Ayllon Teran; Rafael Orti-Rodriguez; Ana Cristina Padial-Aguado; Javier Medina-Fernández; Rosa Ortega-Salas; Gema Pulido-Cortijo; Auxiliadora Gómez-España; Sebastián Rufián-Peña
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries.

Authors:  Harveshp D Mogal; Edward A Levine; Greg Russell; Perry Shen; John H Stewart; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2015-08-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.